window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 26, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CRO

  • Clinical Development,Data Management,Mergers & Acquisitions,Regulatory Affairs,Research & Development

    Veristat acquires Certara regulatory and medical writing business

    Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

    April 22, 2026
  • Biotech,Drug discovery,Facilities and infrastructure,Research & Development,Technology and platforms

    FairJourney Bio opens cryo-EM facility in San Diego for antibody discovery

    FairJourney Bio has opened a cryo-EM structural biology facility in [...]

    April 17, 2026
  • Clinical Development,Drug Development,Healthcare leadership,Movers & Shakers,Neurosciences,Oncology,Rare Diseases

    Allucent adds strategy leaders to expand therapeutic expertise

    Allucent has appointed new therapeutic strategy leaders across key disease [...]

    April 9, 2026
  • CDMOs & Manufacturing,Clinical Trials,Data Management,Technology and platforms

    PSI launches AI platform to improve clinical trial site selection and enrolment

    PSI CRO has launched SYNETIC, an AI-powered semantic knowledge platform [...]

    February 2, 2026
  • Biotech,Digital Health,Technology and platforms

    Research finds scientists view ELNs as ‘glorified filing cabinets’, driving duplication and shadow AI use

    A new survey by Sapio Sciences has found widespread frustration [...]

    January 30, 2026
  • Biotech,CDMOs & Manufacturing,Drug Development,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Onyx Scientific expands material science capabilities as part of 25th anniversary milestone

    Onyx Scientific has expanded its solid form and material science [...]

    January 19, 2026
  • Biotech,Clinical Development,Clinical studies,Clinical Trials,Healthcare leadership,Movers & Shakers,Rare Diseases

    Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth

    Veristat, a global clinical research organization (CRO) and consultancy specializing [...]

    January 15, 2026
  • Artificial Intelligence,Clinical Trials,Digital Health,Movers & Shakers,Technology and platforms

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    October 6, 2025
  • Drug Development,Research & Development,Technology and platforms

    Sygnature Discovery upgrades high-throughput chemistry platform following £1 million investment

    Sygnature Discovery has completed a major upgrade of its high-throughput [...]

    July 23, 2025
  • CDMOs & Manufacturing,Drug Development,Movers & Shakers

    Abzena appoints Geoffrey Glass as CEO to drive next growth phase

    Abzena, the integrated CDMO and CRO specializing in complex biologics [...]

    July 22, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top